Steve Schonfeld’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-17,240
| Closed | -$987K | – | 2241 |
|
|
2025
Q3 | $987K | Buy |
17,240
+2,357
| +16% | +$136K | 0.01% | 1375 |
|
|
2025
Q2 | $878K | Buy |
+14,883
| New | +$962K | 0.01% | 1344 |
|
|
2025
Q1 | – | Sell |
-21,470
| Closed | -$1.78M | – | 2307 |
|
|
2024
Q4 | $1.78M | Buy |
21,470
+16,989
| +379% | +$1.34M | 0.01% | 883 |
|
|
2024
Q3 | $321K | Buy |
+4,481
| New | +$316K | ﹤0.01% | 1626 |
|
|
2024
Q2 | – | Sell |
-16,883
| Closed | -$906K | – | 2310 |
|
|
2024
Q1 | $906K | Sell |
16,883
-7,411
| -31% | -$398K | 0.01% | 1267 |
|
|
2023
Q4 | $1.29M | Buy |
24,294
+11,566
| +91% | +$564K | 0.01% | 945 |
|
|
2023
Q3 | $632K | Sell |
12,728
-41,697
| -77% | -$2.33M | ﹤0.01% | 1148 |
|
|
2023
Q2 | $3.24M | Buy |
+54,425
| New | +$3.1M | 0.03% | 612 |
|
|
2023
Q1 | – | Sell |
-21,151
| Closed | -$1.57M | – | 2289 |
|
|
2022
Q4 | $1.57M | Buy |
21,151
+4,951
| +31% | +$337K | 0.01% | 926 |
|
|
2022
Q3 | $966K | Sell |
16,200
-48,127
| -75% | -$2.9M | 0.01% | 1291 |
|
|
2022
Q2 | $3.61M | Sell |
64,327
-95,346
| -60% | -$6.27M | 0.04% | 560 |
|
|
2022
Q1 | $11.8M | Sell |
159,673
-23,984
| -13% | -$1.67M | 0.11% | 234 |
|
|
2021
Q4 | $13.3M | Buy |
+183,657
| New | +$13.3M | 0.12% | 226 |
|
|
2021
Q3 | – | Sell |
-3,272
| Closed | -$254K | – | 2264 |
|
|
2021
Q2 | $254K | Buy |
+3,272
| New | +$233K | ﹤0.01% | 1549 |
|
|
2020
Q4 | – | Sell |
-14,709
| Closed | -$728K | – | 1675 |
|
|
2020
Q3 | $728K | Sell |
14,709
-3,742
| -20% | -$193K | 0.01% | 800 |
|
|
2020
Q2 | $880K | Buy |
+18,451
| New | +$890K | 0.02% | 636 |
|
|
2020
Q1 | – | Sell |
-5,805
| Closed | -$342K | – | 1278 |
|
|
2019
Q4 | $342K | Buy |
+5,805
| New | +$315K | 0.01% | 908 |
|
|
2018
Q4 | – | Sell |
-31,700
| Closed | -$1.8M | – | 1128 |
|
|
2018
Q3 | $1.8M | Sell |
31,700
-47,878
| -60% | -$2.52M | 0.08% | 308 |
|
|
2018
Q2 | $4.01M | Buy |
79,578
+39,960
| +101% | +$2.08M | 0.22% | 160 |
|
|
2018
Q1 | $1.97M | Buy |
+39,618
| New | +$1.86M | 0.15% | 204 |
|
|
2017
Q2 | – | Sell |
-8,795
| Closed | -$261K | – | 669 |
|
|
2017
Q1 | $261K | Buy |
+8,795
| New | +$240K | 0.03% | 496 |
|
Other funds holding GMED
SC
MAP
Steve Schonfeld's GMED Position: Q4 2025 in Review
Steve Schonfeld sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 17,240 shares — an estimated $987K sold.
Steve Schonfeld first reported a position in GMED in Q1 2017 and held it in 21 quarters. The position peaked at $13.3M in Q4 2021. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.
- Steve Schonfeld reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
- Steve Schonfeld sold 17,240 Globus Medical shares in Q4 2025, an estimated $987K.
- Steve Schonfeld first reported a position in Globus Medical in Q1 2017 and held it in 21 quarters.
- Steve Schonfeld's Globus Medical position peaked at $13.3M in Q4 2021.
- 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.